WorldPingA pill from Sionna Therapeutics provided no added benefit when combined with Vertex's cystic fibrosis blockbuster Trikafta, a blow to the biotech.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STAT
WorldPingBiotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.
Brief by WorldPing · Original reporting by STAT
WorldPingTrading platform eToro will acquire TradeZero as part of its US expansion as it reported crypto-related revenue fell by about 30% compared to the second quarter of 2025.
Brief by WorldPing · Original reporting by Cointelegraph
WorldPingMangione's lawyers have yet to signal their defence, while prosecutors are in a battle over evidence.
Brief by WorldPing · Original reporting by BBC News
WorldPingA coalition of farmers, consumer associations and environmental groups is urging Malaysia’s National Biosafety Board to reject a proposed field trial of genetically modified rice…
Brief by WorldPing · Original reporting by ABC News
WorldPingKeel completed the shutdown of its US Bitcoin mining operations as it pivots toward AI and high-performance computing infrastructure…
Brief by WorldPing · Original reporting by Cointelegraph
WorldPing